APA (7th ed.) Citation

JS, B., AR, H., C, A., M, O., E, H., E, P., . . . JL, T. (2026). Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers. Molecular therapy : the journal of the American Society of Gene Therapy, 34(5), 2653. https://doi.org/10.1016/j.ymthe.2026.01.021

Chicago Style (17th ed.) Citation

JS, Barber-Rotenberg, et al. "Phase 1 Study of Autologous T Cells Bearing Fully Human Chimeric Antigen Receptors Targeting Mesothelin in Mesothelin-expressing Cancers." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 5 (2026): 2653. https://doi.org/10.1016/j.ymthe.2026.01.021.

MLA (9th ed.) Citation

JS, Barber-Rotenberg, et al. "Phase 1 Study of Autologous T Cells Bearing Fully Human Chimeric Antigen Receptors Targeting Mesothelin in Mesothelin-expressing Cancers." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 5, 2026, p. 2653, https://doi.org/10.1016/j.ymthe.2026.01.021.